Transatlantic Trade and Investment Partnership

Liz McInnes Excerpts

Thursday 15th January 2015 Commons Chamber

[Liz McInnes (Heywood and Middleton) (Lab)]

In my previous employment as an NHS scientist, I was extremely concerned about the implications of TTIP for our NHS, and for all our public services, and I remain so. In my new job, I have been contacted by many constituents expressing their concern about TTIP, which is a subject on which the public appear to be very well informed.

[Mr Slaughter]

My hon. Friend has hit the nail on the head. Members of Parliament are not putting pressure on their constituents, as the hon. Member for Totnes (Dr Wollaston) claimed; rather, constituents are saying that they are concerned. They are concerned, for example, that small businesses are being disadvantaged in comparison with large businesses, that monopolies are being encouraged among pharmaceutical companies, and that the NHS is in danger of privatisation. We have a duty to give them an explanation. There is huge disquiet out there among the public, and we ought to address it. There is terrible complacency among Government Members about this.

[Liz McInnes]

I thank my hon. Friend for his comments; he has pre-empted what I was about to say. I am not going out scaremongering; my constituents and my previous colleagues are expressing to me their real and legitimate concerns about this agreement.

As I said, this is a subject on which the public appear to be very well informed. That surprises me, given that a major concern expressed to me is that the negotiations seem to be taking place in secret. Perhaps there is a lesson here: the more secretive a deal appears to be, the more effort people will make to try to seek out the truth. If ever we needed an argument for openness and transparency, this is it.

We have already heard a lot about the ISDS mechanism, which is causing my constituents and ex-colleagues major concern, particularly in relation to our public services—specifically, our NHS. People are telling me— again, this is not about me going out scaremongering—that they are really worried that this could result in private companies seeking compensation from our public bodies for loss of potential earnings. We have already heard about mechanisms in agreements in other countries whereby those countries are being sued for things such as regulating medicine and energy prices, raising minimum wages, and putting health warnings on cigarette packets, to name but a few. There is a real fear that this mechanism is not about enforcing contracts but about giving businesses huge new powers to intimidate policy makers. There is major concern that the ISDS provisions could lead to enforced privatisation of our NHS and other public services. Governments have a right to be able to legislate in the public interest, and that should be protected in any dispute resolution mechanisms.

The European Commission has instigated several changes that have improved the transparency of the agreement, and that is welcome. However, it is right that the Commission has decided temporarily to suspend negotiation on ISDS until the final stages of the negotiations. I urge the Government to use this opportunity to call for greater transparency on exclusion for legislation that is in the public interest, such as that relating to the NHS.

An online consultation by the European Commission has revealed huge public opposition to TTIP. Again, this is not about me or any other member of my party going around scaremongering. The Commission received an unprecedented 150,000 responses, more than a third of which were from the UK, mainly opposing TTIP and many calling for the NHS and other public services to be exempt from it.

Other countries have sought to exempt areas from the agreement, but this Government have not done so. Instead, their position on the NHS and TTIP has been muddled. They have told the British Medical Association that the NHS will be “protected”, and the Department of Health has said:

“We have no intention of allowing the TTIP to dictate the opening up of NHS services to further competition, and it will not do so.”

However, the Minister for Trade and Investment, Lord Livingston, said in September that TTIP would not have any impact on the NHS and therefore the UK negotiation team would not be pushing for its exclusion. Those mixed messages are of great concern and are troubling. This Government need to commit to the NHS being exempt from the final TTIP agreement and look carefully at its impact on other public services.